Siliq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe psoriasis in adults. Siliq may be prescribed in cases where systemic therapy and phototherapy are warranted and other systemic medications have failed or become less effective. Siliq is also known by its drug name, brodalumab.
Siliq is an immunomodulator, or drug that modulates the immune system. Siliq is also a biologic drug. Siliq is believed to work by blocking the effects of molecules called interleukins that contribute to inflammation in psoriasis.
How do I take it?
Siliq is administered as a subcutaneous injection every two weeks after initial loading doses.
Siliq comes in the form of a prefilled, single-use syringe.
The FDA-approved label for Siliq lists common side effects including joint pain, headache, fatigue, diarrhea, sinus pain, nausea, chest pain, injection site reactions, flu, and low blood cell counts.
Rare but serious side effects listed for Siliq include suicidal thoughts and behavior, severe or worsening infections, and Crohn’s disease.
For more details about this treatment, visit:
Siliq — Ortho Dermatologics
FDA approves new psoriasis drug — US Food and Drug Administration